WASHINGTON, D.C. — The U.S. Senate unanimously approved legislation Thursday to end a loophole that allows designer anabolic steroids to easily be found online, in gyms, and even in retail stores. The Designer Anabolic Steroid Control Act, sponsored by U.S. Sens. Sheldon Whitehouse and Orrin Hatch, will help protect consumers from these harmful products by properly classifying them as controlled substances, according to a statement released by Hatch’s office Friday. The legislation also imposes civil penalties for importing, manufacturing, or distributing designer anabolic steroids under false labels.
The bill was approved by the House of Representatives in September, and will now be sent to the President to be signed into law.
See the full text of the Act here: Designer Anabolic Steroid Control Act of 2014
“The world’s top athletes are subject to strict guidelines and rigorous testing to prevent the use of steroids, as they should be,” Whitehouse said. “At the same time, many American citizens may be unknowingly dosing themselves with these harmful substances. American consumers deserve to know what is in the products they purchase. This bill will help prevent the sale of falsely labeled steroids, and I’m glad it will become law. I thank Senator Hatch for his support and Judiciary Chairman Leahy for enabling this bill to move forward.”
“This is a commonsense bill that will protect consumers by giving DEA the tools and authority to remove dangerous steroids from the market,” Hatch said. “I’m pleased Senator Whitehouse and I could work together in bipartisan fashion to help make this important law a reality.”
Designer steroids are produced by reverse engineering existing illegal steroids and then slightly modifying their chemical composition, so the resulting product is not on the Drug Enforcement Administration’s list of controlled substances. When taken by consumers, designer steroids can cause serious medical harm, including liver injury and increased risk of heart attack and stroke. They may also lead to aggression, hostility, and addiction.
The Designer Anabolic Steroid Control Act would:
- Immediately place 25 known designer anabolic steroids on the list of controlled substances;
- Grant the DEA authority to temporarily schedule new designer steroids on the controlled substances list, so that if bad actors develop new variations, these products can be removed from the market;
- Create new penalties for importing, manufacturing, or distributing anabolic steroids under false labels; and
- Authorize the Attorney General to publish a list of products containing an anabolic steroid that are not properly labeled.
The legislation was supported by a coalition of organizations, including the American Academy of Family Physicians, American Association of Nurse Practitioners, American Pharmacists’ Association, Council for Responsible Nutrition and United States Anti-Doping Agency.
Submitted by the Offices of Sen. Orrin Hatch
- Cocaine use, manufacturing steroids, lands man in jail
- Hatch, Whitehouse introduce bipartisan bill to crack down on steroids
- Hatch recognizes Utah’s $7 billion nutritional products industry
- Hatch rebukes EPA for costly new regulations